MultiOmic Health to Present at Bio€quity Europe 2024
We’re thrilled to announce our participation at #BioEquityEurope 2024!
Robert Thong, our CEO at MultiOmic Health, will be presenting on our innovative approach to tackle cardiorenal complications. Join us for insights into how we aim to transform the landscape of metabolic syndrome through precision medicine.
Bio€quity Europe Metabolic Syndrome Multiomic Health Precision Medicine
Leveraging AI to Tackle the Looming Metabolic Syndrome Crisis
In this article, we look at how Mesh Bio and MultiOmic Health use AI to transform and improve the lives of metabolic syndrome patients through patient stratification and precision medicine.
AI Drug Discovery Mesh Bio Metabolic Syndrome Multiomic Health